why choose us

First received: December 27, 2022

Clinical Trial: A HR20031 BE Study on Healthy Subjects

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Type 2 Diabetes

Study Type: Interventional


Official Title: A Bioequivalence Study of HR20031 Tablet in Healthy Subjects

Brief Summary: The purpose of this study is to assess the bioequivalence between HR20031 FDC tablet and co-administration of SHR3824 tablets, SP2086 tablets and metformin XR tablets.

Read more